Denbury Res (DNR) Market Value Rose While Nomura Asset Management Company LTD Has Trimmed Stake by $385,574; Ra Capital Management Stake in Endocyte (ECYT) Boosted by $4.65 Million as Stock Value Rose

June 14, 2018 - By Winifred Garcia

Denbury Resources Inc. (NYSE:DNR) Logo

Peter Kolchinsky increased its stake in Endocyte Inc (ECYT) by 15.37% based on its latest 2018Q1 regulatory filing with the SEC. Ra Capital Management Llc bought 517,145 shares as the company’s stock rose 213.65% while stock markets declined. The hedge fund run by Peter Kolchinsky held 3.88M shares of the health care company at the end of 2018Q1, valued at $35.29M, up from 3.36M at the end of the previous reported quarter. Ra Capital Management Llc who had been investing in Endocyte Inc for a number of months, seems to be bullish on the $991.09 million market cap company. The stock decreased 0.97% or $0.14 during the last trading session, reaching $14.26. About 457,988 shares traded. Endocyte, Inc. (NASDAQ:ECYT) has risen 444.08% since June 14, 2017 and is uptrending. It has outperformed by 431.51% the S&P500. Some Historical ECYT News: 15/03/2018 – Endocyte: Keith Brauer, Ann Hanham and Peter Meldrum Won’t Stand for Re-election to Board; 09/05/2018 – Endocyte Announces The Lancet Oncology Publication of Phase 2 Data From lnvestigator-lnitiated Prostate Cancer Trial of (177)Lu-PSMA-617; 14/05/2018 – Great Point Partners Buys New 2.1% Position in Endocyte; 09/05/2018 – Endocyte Has Cash to Fund Activities Through the Expected End of the VISION Trial and Potential Proof of Concept of Its EC17/CAR T-cell Therapy; 09/05/2018 – ENDOCYTE:-PHASE 3 VISION TRIAL ON TRACK FOR FIRST PATIENT VISIT; 09/05/2018 – ENDOCYTE: PUBLICATION REFLECTS LONGER MEDIAN OVERALL SURVIVAL; 09/05/2018 – ENDOCYTE INC – CASH, CASH EQUIVALENTS AND INVESTMENTS WERE $173.1 MLN AT MARCH 31, 2018; 15/03/2018 Endocyte Nominates Dawn Svoronos for Election to Its Board of Directors and Announces Other Board Developments; 15/03/2018 – Endocyte Announces Presentations at American Association for Cancer Research (AACR) Annual Meeting 2018; 15/05/2018 – Venbio Select Advisor Buys New 8.2% Position in Endocyte

Nomura Asset Management Company Ltd decreased its stake in Denbury Res Inc (DNR) by 78.96% based on its latest 2018Q1 regulatory filing with the SEC. Nomura Asset Management Company Ltd sold 192,787 shares as the company’s stock rose 65.53% while stock markets declined. The institutional investor held 51,361 shares of the oil & gas production company at the end of 2018Q1, valued at $141,000, down from 244,148 at the end of the previous reported quarter. Nomura Asset Management Company Ltd who had been investing in Denbury Res Inc for a number of months, seems to be less bullish one the $1.77B market cap company. The stock decreased 1.67% or $0.07 during the last trading session, reaching $4.11. About 4.55M shares traded. Denbury Resources Inc. (NYSE:DNR) has risen 124.86% since June 14, 2017 and is uptrending. It has outperformed by 112.29% the S&P500. Some Historical DNR News: 08/05/2018 – DENBURY RESOURCES INC – BANK CREDIT FACILITY BORROWING BASE REAFFIRMED AT $1.05 BLN; 08/05/2018 – Denbury Resources !Q Adjusted Cash Flow From Operations $125M; 19/04/2018 – DJ Denbury Resources Inc, Inst Holders, 1Q 2018 (DNR); 08/05/2018 – DENBURY – 2018 CAPITAL BUDGET, EXCLUDING ACQUISITIONS & CAPITALIZED INTEREST, REMAINS UNCHANGED FROM PREVIOUSLY ESTIMATED RANGE; 02/04/2018 Denbury Resources at IPAA Oil & Gas Conference Apr 10; 08/05/2018 – Denbury Resources 1Q Rev $348M; 08/05/2018 – Denbury Resources 1Q Net $39.6M; 08/05/2018 – CNBC Wires: Denbury Resources: 1Q Earnings Snapshot; 08/05/2018 – Denbury Resources Reports Successful Additional Mission Canyon Wells; 14/05/2018 – DENBURY RESOURCES INC DNR.N : KLR GROUP RAISES TARGET PRICE TO $4

Investors sentiment increased to 1.52 in Q1 2018. Its up 0.62, from 0.9 in 2017Q4. It increased, as 17 investors sold DNR shares while 48 reduced holdings. 36 funds opened positions while 63 raised stakes. 343.21 million shares or 8.15% more from 317.35 million shares in 2017Q4 were reported. Bridgeway Cap Mngmt has 2.41 million shares. 37,589 were accumulated by Commonwealth Of Pennsylvania Pub School Empls Retrmt. Bancorporation Of Montreal Can reported 0% of its portfolio in Denbury Resources Inc. (NYSE:DNR). The New York-based Jefferies Gru Llc has invested 0.02% in Denbury Resources Inc. (NYSE:DNR). Capital Research stated it has 33.04M shares or 0.03% of all its holdings. Parkside Bancshares & Tru stated it has 308 shares or 0% of all its holdings. Moreover, Fiera Capital Corporation has 0.01% invested in Denbury Resources Inc. (NYSE:DNR). Endurance Wealth Mgmt holds 0.4% or 871,486 shares in its portfolio. Hsbc Holdings Plc has invested 0% in Denbury Resources Inc. (NYSE:DNR). Price T Rowe Associate Md holds 133,046 shares. Atlantic Tru Group Inc Limited Liability Company reported 28,900 shares. Elm Ridge Management Ltd Liability Com has invested 4.18% in Denbury Resources Inc. (NYSE:DNR). Alps Advsrs Inc has invested 0% in Denbury Resources Inc. (NYSE:DNR). Ameritas Invest Ptnrs Inc, a Nebraska-based fund reported 30,377 shares. Alliancebernstein Lp has invested 0.01% in Denbury Resources Inc. (NYSE:DNR).

Analysts await Denbury Resources Inc. (NYSE:DNR) to report earnings on August, 14. DNR’s profit will be $34.47 million for 12.84 P/E if the $0.08 EPS becomes a reality. After $0.12 actual EPS reported by Denbury Resources Inc. for the previous quarter, Wall Street now forecasts -33.33% negative EPS growth.

Nomura Asset Management Company Ltd, which manages about $32.64 billion and $9.16 billion US Long portfolio, upped its stake in Square Inc by 331,300 shares to 1.83M shares, valued at $90.11M in 2018Q1, according to the filing. It also increased its holding in Shinhan Financial Group Co L (NYSE:SHG) by 12,000 shares in the quarter, for a total of 218,300 shares, and has risen its stake in Cintas Corp (NASDAQ:CTAS).

Among 13 analysts covering Denbury Resources Inc. (NYSE:DNR), 1 have Buy rating, 2 Sell and 10 Hold. Therefore 8% are positive. Denbury Resources Inc. had 43 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Tuesday, January 16 by Mizuho. As per Tuesday, April 26, the company rating was initiated by KeyBanc Capital Markets. RBC Capital Markets maintained it with “Hold” rating and $1.5 target in Friday, November 3 report. As per Tuesday, September 8, the company rating was downgraded by Credit Suisse. KLR Group downgraded Denbury Resources Inc. (NYSE:DNR) on Monday, May 14 to “Hold” rating. RBC Capital Markets maintained the stock with “Sector Perform” rating in Monday, February 22 report. The firm has “Hold” rating given on Wednesday, December 20 by RBC Capital Markets. The stock has “Hold” rating by Stifel Nicolaus on Friday, August 18. On Tuesday, September 8 the stock rating was downgraded by Cowen & Co to “Market Perform”. On Monday, February 26 the stock rating was maintained by BMO Capital Markets with “Hold”.

Another recent and important Denbury Resources Inc. (NYSE:DNR) news was published by Fool.com which published an article titled: “Why Denbury Resources, MB Financial, and World Wrestling Entertainment Jumped Today” on May 21, 2018.

Since April 5, 2018, it had 0 insider purchases, and 5 selling transactions for $327,625 activity. Shares for $170,000 were sold by McMichael Greg.

Since March 9, 2018, it had 0 buys, and 2 selling transactions for $242,735 activity.

Among 6 analysts covering Endocyte (NASDAQ:ECYT), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Endocyte had 11 analyst reports since August 5, 2015 according to SRatingsIntel. Cowen & Co maintained the shares of ECYT in report on Friday, June 2 with “Hold” rating. The stock of Endocyte, Inc. (NASDAQ:ECYT) has “Neutral” rating given on Monday, June 5 by Wedbush. Wedbush upgraded the stock to “Outperform” rating in Tuesday, October 3 report. The rating was maintained by RBC Capital Markets on Wednesday, August 5 with “Outperform”. The company was initiated on Thursday, January 21 by Credit Suisse. The stock of Endocyte, Inc. (NASDAQ:ECYT) has “Outperform” rating given on Tuesday, February 27 by Cowen & Co. The stock of Endocyte, Inc. (NASDAQ:ECYT) has “Market Perform” rating given on Monday, June 5 by Cowen & Co. RBC Capital Markets maintained Endocyte, Inc. (NASDAQ:ECYT) on Wednesday, November 4 with “Outperform” rating. Cowen & Co maintained the shares of ECYT in report on Monday, October 2 with “Hold” rating.

Ra Capital Management Llc, which manages about $1.48B and $1.31 billion US Long portfolio, decreased its stake in Avexis Inc by 142,989 shares to 1.03 million shares, valued at $127.08 million in 2018Q1, according to the filing. It also reduced its holding in Krystal Biotech Inc by 203,929 shares in the quarter, leaving it with 496,071 shares, and cut its stake in Sunesis Pharmaceuticals Inc.

Denbury Resources Inc. (NYSE:DNR) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Winifred Garcia

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: